WellMedRx Review
Best for: Patients comfortable revealing payment information at intake to access bundled GLP-1 + TRT or GLP-1 + hair-loss care from a single multi-product platform; not suitable for cost-comparison shoppers given lack of public pricing.
WellMedRx (wellmedr.com) is a multi-product compounded telehealth platform operated by Wellmedr LLC with clinical services provided by OpenLoop Health and other U.S.-licensed clinician networks. Compounded GLP-1/GIP (tirzepatide) and microdose semaglutide (with NAD+ and B12) are fulfilled by Mycelium Pharmacy, a named licensed pharmacy partner. Public pricing is not disclosed beyond a '50% off your first month' promotion; medication costs are bundled into the 'Wellmedr care coaching program.' Multi-vertical: weight loss, testosterone (enclomiphene + anastrozole), hair loss, and sexual health. HIPAA badge displayed; no LegitScript number or .pharmacy seal visible on home page; state list not publicly disclosed (live-verified 2026-05-15).
Low confidence · Last verified 2026-05-15 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
WellMedRx is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
WellMedRx prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Not publicly disclosed (50% off first month promo only) | compounded | $0 |
| Microdose w/ NAD+ + B12 (price not disclosed) | compounded | $0 |
✓ Pros
- •Named licensed pharmacy partner (Mycelium Pharmacy) disclosed verbatim
- •Clinical care delivered through OpenLoop Health (established telehealth clinician network)
- •Multi-product platform — single account covers weight loss, TRT, hair, sexual health
- •HIPAA-compliant badge on home page
✗ Cons
- •Per-dose monthly pricing NOT publicly visible — requires intake to surface cost
- •State coverage list not disclosed on website ('licensed professional in your state' only)
- •No LegitScript registration number visible on home page
- •No NABP .pharmacy seal
- •Compounded tirzepatide/semaglutide are NOT FDA-approved finished drug products
- •Corporate address, named medical director not disclosed
Ready to start with WellMedRx?
Starting at $0/month. See current pricing and start your free consultation.
Sources & methodology
Our WellMedRx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to WellMedRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with WellMedRx?
Starting at $0/month. See current pricing and start your free consultation.